Technische Universität Dresden

The Dilemma of Reproducibility of Gating Isotherms for Flexible MOFs (2022) De A, Maliuta M, Senkovska I, Kaskel S Journal article Collective cell migration during optic cup formation features changing cell-matrix interactions linked to matrix topology (2022) Soans KG, Ramos AP, Sidhaye J, Krishna A, Solomatina A, Hoffmann KB, Schlüßler R, et al. Journal article Warmforming Flow Pressing Characteristics of Continuous Fibre Reinforced Thermoplastic Composites (2022) Gröger B, Römisch D, Kraus M, Troschitz J, Füßel R, Merklein M, Gude M Journal article, Original article Structure-Imposed Electronic Topology in Cove-Edged Graphene Nanoribbons (2022) Arnold FM, Liu TJ, Kuc A, Heine T Journal article Human-machine-communication: introduction to the special issue (2022) Etzrodt K, Gentzel P, Utz S, Engesser S Journal article Ba(BO2OH) – A Monoprotonated Monoborate from Hydroflux Showing Intense Second Harmonic Generation (2022) Li Y, Hegarty PA, Ruesing M, Eng LM, Ruck M Journal article Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST) (2022) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial (2022) Roellig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Haenel M, et al. Conference contribution Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis (2022) Unglaub JM, Schlenk RF, Hanoun M, Reinhardt HC, Middeke JM, Schaefer-Eckart K, Steffen B, et al. Conference contribution In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial (2022) Stelljes M, Middeke JM, Bug G, Wagner EM, Mueller LP, Christoph S, Krause S, et al. Conference contribution